Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexei V Salnikov

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncoimmunology|August 31, 2012
Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancerIngrid Herr, Ariane Groth, Alexei V Salnikov, et al.
Journal of Plant Physiology|May 9, 2015
Expression and properties of the glyoxysomal and cytosolic forms of isocitrate lyase in Amaranthus caudatus LAlexander T Eprintsev, Dmitry N Fedorin, Alexei V Salnikov, et al.
International Journal of Cancer|August 14, 2009
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patientsAlexei V Salnikov, Jury Gladkich, Gerhard Moldenhauer, et al.
Journal of the National Cancer Institute|March 30, 2012
Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinomaGerhard Moldenhauer, Alexei V Salnikov, Sandra Lüttgau, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2005
Inhibition of TGF-beta modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinomaAlexei V Salnikov, Pernilla Roswall, Christian Sundberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2007
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studiesMarc-André Fortin, Alexei V Salnikov, Marika Nestor, et al.
International Journal of Cancer|October 5, 2006
Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinomaAlexei V Salnikov, Nils-Erik Heldin, Linda B Stuhr, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 21, 2009
Peritumoral TNFalpha administration influences tumour stroma structure and physiology independently of growth in DMBA-induced mammary tumoursLinda E B Stuhr, Ingrid Moen, Torbjørn Nedrebø, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2007
Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinomaAke Oldberg, Sebastian Kalamajski, Alexei V Salnikov, et al.
Clinical & Experimental Metastasis|October 11, 2011
CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashionNiko Bretz, Aurelia Noske, Sascha Keller, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncoimmunology|August 31, 2012
Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancerIngrid Herr, Ariane Groth, Alexei V Salnikov, et al.
Journal of Plant Physiology|May 9, 2015
Expression and properties of the glyoxysomal and cytosolic forms of isocitrate lyase in Amaranthus caudatus LAlexander T Eprintsev, Dmitry N Fedorin, Alexei V Salnikov, et al.
International Journal of Cancer|August 14, 2009
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patientsAlexei V Salnikov, Jury Gladkich, Gerhard Moldenhauer, et al.
Journal of the National Cancer Institute|March 30, 2012
Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinomaGerhard Moldenhauer, Alexei V Salnikov, Sandra Lüttgau, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 16, 2005
Inhibition of TGF-beta modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinomaAlexei V Salnikov, Pernilla Roswall, Christian Sundberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2007
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studiesMarc-André Fortin, Alexei V Salnikov, Marika Nestor, et al.
International Journal of Cancer|October 5, 2006
Inhibition of carcinoma cell-derived VEGF reduces inflammatory characteristics in xenograft carcinomaAlexei V Salnikov, Nils-Erik Heldin, Linda B Stuhr, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 21, 2009
Peritumoral TNFalpha administration influences tumour stroma structure and physiology independently of growth in DMBA-induced mammary tumoursLinda E B Stuhr, Ingrid Moen, Torbjørn Nedrebø, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2007
Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinomaAke Oldberg, Sebastian Kalamajski, Alexei V Salnikov, et al.
Clinical & Experimental Metastasis|October 11, 2011
CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashionNiko Bretz, Aurelia Noske, Sascha Keller, et al.
Pageof 3